IQVIA Holdings Inc.

IQV Healthcare Diagnostics & Research

IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS was flat, free cash flow grew 23.3% and total debt rose 3.29%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.

266.90 4.14 −1.53%
Market cap
$44.6B
P/E
32.8×
Fwd P/E
22.3×
Dividend yield
—
F-score
4/9
Altman Z
2.05
Beneish M
−2.59
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
23.77 20.95 28.43 25.84

+8 more quarters

P/S ratio
1.89 1.73 2.38 2.03
P/FCF ratio
14.21 13.11 18.23 14.14
P/Operating CF
57.52 46.47 52.72 35.60
P/B ratio
5.09 4.52 5.84 5.14
EV/Sales
2.71 2.55 3.21 2.85
EV/EBITDA
13.51 12.52 15.63 13.60
EV/FCF
20.37 19.37 24.61 19.82
Current Ratio
0.71 0.75 0.75 0.70
Net Debt/EBITDA
17.31 16.99 14.30 15.37
Debt/Equity
2.54 2.49 2.37 2.38
Earnings Yield
4.21% 4.77% 3.52% 3.87%
Free Cash Flow Yield
7.04% 7.63% 5.49% 7.07%
Free Cash Flow per Share
2.17 2.92 3.26 4.98
Book value per Share
37.94 37.70 38.57 36.94
Free Cash Flow
360.00 491.00 561.00 847.00
EV/EBIT
20.91 19.30 23.98 20.78
Other line items

Show all line items

Columns are period end dates